Table of Contents
Morphine is a potent opioid analgesic widely used for pain management. Understanding its pharmacokinetics and metabolism is essential for optimizing therapeutic effects and minimizing adverse reactions.
Pharmacokinetics of Morphine
The pharmacokinetics of morphine involves its absorption, distribution, metabolism, and excretion. After administration, morphine is absorbed into the bloodstream and distributed throughout the body, crossing the blood-brain barrier to exert its analgesic effects.
Absorption
Oral morphine is absorbed through the gastrointestinal tract with a bioavailability of approximately 30-40% due to first-pass metabolism in the liver. Parenteral routes, such as intravenous or intramuscular injections, bypass first-pass metabolism, leading to higher bioavailability.
Distribution
Morphine is widely distributed in body tissues and fluids. It has a volume of distribution (Vd) of about 3-4 L/kg. The drug crosses the blood-brain barrier and placental barrier, which is significant in pain control and pregnancy considerations.
Metabolism
Metabolism primarily occurs in the liver through conjugation with glucuronic acid. Morphine is mainly metabolized into two inactive metabolites: morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). M6G is an active metabolite contributing to analgesic effects.
Metabolism of Morphine
The hepatic enzyme UDP-glucuronosyltransferase (UGT2B7) catalyzes the conjugation process. The ratio of metabolites varies among individuals, influenced by genetic factors, age, liver function, and concurrent medications.
Active and Inactive Metabolites
- Morphine-6-glucuronide (M6G): An active metabolite with potent analgesic properties.
- Morphine-3-glucuronide (M3G): An inactive metabolite associated with neuroexcitatory side effects in some cases.
Excretion
Excretion occurs primarily via the kidneys. Approximately 90% of the administered dose is excreted in urine within 24 hours, mainly as conjugated metabolites. Impaired renal function can lead to accumulation of metabolites, increasing the risk of toxicity.
Clinical Implications
Understanding morphine’s pharmacokinetics and metabolism helps in dose adjustment, especially in patients with liver or kidney impairment. It also guides the choice of administration route and monitoring for adverse effects such as respiratory depression and neurotoxicity.